MRI co Clear Cut Medical raises NIS 2.8m

The company's MRI can detect the surgical margins during the procedure to ensure excision of the entire tumor.

Clear Cut Medical Ltd., which is developing a compact MRI device for assisting breast cancer surgery, has raised NIS 2.8 million from new and current investors. The company's MRI can detect the surgical margins during the procedure to ensure excision of the entire tumor.

Clear Cut Medical is a portfolio of Ashkelon Technological Industries (ATI), a subsidiary of Gefen Biomed Investments Ltd. (TASE: GEFEN). Gefen's share in the company fell from 29.8% to 24% following the financing.

Clear Cut Medical resembles the device of Dune Medical Devices Ltd., which has developed a radio-frequency (RF) device for the immediate assessment of breast cancer on the margin of excised tissue.

Published by Globes [online], Israel business news - www.globes-online.com - on November 15, 2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
MORE FROM GLOBES
Twitter Facebook Linkedin RSS Newsletters גלובס